Details for New Drug Application (NDA): 040529
✉ Email this page to a colleague
NDA 040529 describes METHAMPHETAMINE HYDROCHLORIDE, which is a drug marketed by Able, Dr Reddys Labs Sa, Hikma, Rexar, and Teva, and is included in five NDAs. It is available from two suppliers. Additional details are available on the METHAMPHETAMINE HYDROCHLORIDE profile page.
The generic ingredient in METHAMPHETAMINE HYDROCHLORIDE is methamphetamine hydrochloride. There are six drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the methamphetamine hydrochloride profile page.
The generic ingredient in METHAMPHETAMINE HYDROCHLORIDE is methamphetamine hydrochloride. There are six drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the methamphetamine hydrochloride profile page.
Summary for 040529
| Tradename: | METHAMPHETAMINE HYDROCHLORIDE |
| Applicant: | Able |
| Ingredient: | methamphetamine hydrochloride |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 040529
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 5MG | ||||
| Approval Date: | Feb 25, 2004 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
